Showing results (1381-1390 of 1,493) with videos related to
Sort By:
Pageof 150
Journal of Virological Methods|June 25, 2003
Serotype-specific detection of enterovirus 71 in clinical specimens by DNA microchip arrayShin-Ru Shih, Yih-Weng Wang, Guang-Wu Chen, et al.Oncotarget|August 27, 2015
ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinomaCamilla Krakstad, Ingvild L Tangen, Erling A Hoivik, et al.Plos One|March 6, 2014
Quantitative assessment of the presence and severity of cirrhosis in patients with hepatitis B using right liver lobe volume and spleen size measured at magnetic resonance imagingXiao-Li Chen, Tian-Wu Chen, Xiao-Ming Zhang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 13, 2019
Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unitEmily Han-Chung Hsiue, Pei-Lin Lee, Yung-Hsuan Chen, et al.Nature Communications|February 23, 2024
Evolution and expression patterns of the neo-sex chromosomes of the crested ibisLulu Xu, Yandong Ren, Jiahong Wu, et al.Environment International|March 9, 2024
Susceptibility of hypertensive individuals to acute blood pressure increases in response to personal-level environmental temperature decreaseYifan Xu, Yiqun Han, Wu Chen, et al.Proceedings of the National Academy of Sciences of the United States of America|October 9, 2024
Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogrammingYatian Yang, Xiong Zhang, Demin Cai, et al.Epilepsia|October 27, 2025
De novo SRCAP variants cause developmental and epileptic encephalopathy and the phenotypic spectrumXiao-Yu Liang, Xiang-Hong Meng, Wu-Chen Wu, et al.Acta Pharmaceutica Sinica. B|December 23, 2020
Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylinJianwei Zheng, Junfeng Wang, Qian Wang, et al.Drug Design, Development and Therapy|March 21, 2015
Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathwayNing-Kui Niu, Zi-Li Wang, Shu-Ting Pan, et al.Pageof 150